Cardioprotective and nephroprotective effects of angiotensin converting enzyme inhibitor ramipril

被引：0
作者：
Napalkov, D. A. [1 ]
Golovenko, E. N. [1 ]
机构：
[1] Moscow Med Acad, Bolshaya Pirogovskaya Ul 6, Moscow 119991, Russia
来源：
RATIONAL PHARMACOTHERAPY IN CARDIOLOGY | 2009年 / 5卷 / 02期
关键词：
ramipril; ACE inhibitor; arterial hypertension; albuminuria; left ventricle hypertrophy; atrial fibrillation;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
There is grate interest to ACE inhibitors which have cardioprotective and neproprotective effects. Ramipril efficacy in ischemic heart disease prevention as well as ramipril positive effect on myocardium in adolescents is presented on the base of some trails. Ramipril ability to delay of diabetic and non-diabetic nephropathy progression is also discussed.
引用
收藏
页码：79 / 82
页数：4
相关论文
共 22 条
  • [1] BALL SG, 1993, LANCET, V342, P821
  • [2] Prevention of Recurrent Lone Atrial Fibrillation by the Angiotensin-II Converting Enzyme Inhibitor Ramipril in Normotensive Patients
    Belluzzi, Fabio
    Sernesi, Laura
    Preti, Paola
    Salinaro, Francesco
    Fonte, Maria Luisa
    Perlini, Stefano
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 53 (01) : 24 - 29
  • [3] RENAL PROTECTIVE EFFECT OF ENALAPRIL IN DIABETIC NEPHROPATHY
    BJORCK, S
    MULEC, H
    JOHNSEN, SA
    NORDEN, G
    AURELL, M
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 1992, 304 (6823): : 339 - 343
  • [4] Follow-up study of patients randomly allocated ramipril or placebo for heart failure after acute myocardial infarction: AIRE Extension (AIREX) study
    Hall, AS
    Murray, GD
    Ball, SG
    [J]. LANCET, 1997, 349 (9064) : 1493 - 1497
  • [5] EFFECT OF ANTIHYPERTENSIVE THERAPY ON THE KIDNEY IN PATIENTS WITH DIABETES - A METAREGRESSION ANALYSIS
    KASISKE, BL
    KALIL, RSN
    MA, JZ
    LIAO, MJ
    KEANE, WF
    [J]. ANNALS OF INTERNAL MEDICINE, 1993, 118 (02) : 129 - 138
  • [6] THE EFFECT OF ANGIOTENSIN-CONVERTING ENZYME-INHIBITION ON DIABETIC NEPHROPATHY
    LEWIS, EJ
    HUNSICKER, LG
    BAIN, RP
    ROHDE, RD
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (20) : 1456 - 1462
  • [7] EMERGING ROLE OF ANGIOTENSIN-CONVERTING ENZYME-INHIBITORS IN CARDIAC AND VASCULAR PROTECTION
    LONN, EM
    YUSUF, S
    JHA, P
    MONTAGUE, TJ
    TEO, KK
    BENEDICT, CR
    PITT, B
    [J]. CIRCULATION, 1994, 90 (04) : 2056 - 2069
  • [8] Effects of low dose ramipril on cardiovascular and renal outcomes in patients with type 2 diabetes and raised excretion of urinary albumin:: randomised, double blind, placebo controlled trial (the DIABHYCAR study)
    Marre, M
    Lievre, M
    Chatellier, G
    Mann, JFE
    Passa, P
    Ménard, J
    [J]. BRITISH MEDICAL JOURNAL, 2004, 328 (7438): : 495 - 499
  • [9] LONG-TERM ANTIHYPERTENSIVE TREATMENT INHIBITING PROGRESSION OF DIABETIC NEPHROPATHY
    MOGENSEN, CE
    [J]. BRITISH MEDICAL JOURNAL, 1982, 285 (6343) : 685 - 688
  • [10] Low-dose ramipril reduces microalbuminuria in type 1 diabetic patients without hypertension results of a randomized controlled trial - Results of a randomized controlled trial
    O'Hare, JP
    Bilous, R
    Mitchell, T
    O'Callaghan, CJ
    Viberti, GC
    Willoughby, R
    Riley, J
    Robinson, AM
    Reckless, JP
    Havard, F
    Sampson, M
    Lloyd, A
    Williams, T
    Vora, J
    Chattington, P
    Hampson, K
    Ibrahim, H
    Borthwick, L
    Willoughby, R
    Viberti, G
    Russell, C
    Barnes, D
    Macklin, A
    Murphy, E
    Stephens, E
    Vincent, J
    Tindall, H
    Simpson, H
    Knowles, E
    Cunningham, B
    Simpson, E
    Bilous, R
    Bilous, M
    Mitchell, T
    O'Halloran, D
    Nugent, S
    Hadden, D
    Fetherstone, M
    McCarton, D
    McGurk, C
    Johnston, C
    Burton, J
    Harris, C
    Hempstead, H
    Baksi, A
    Bartlett, J
    Heaton, C
    Brown, K
    Arora, A
    Burke, J
    [J]. DIABETES CARE, 2000, 23 (12) : 1823 - 1829
123